These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


180 related items for PubMed ID: 12901871

  • 1. Tartrate-resistant acid phosphatase 5B circulates in human serum in complex with alpha2-macroglobulin and calcium.
    Ylipahkala H, Halleen JM, Kaija H, Vihko P, Väänänen HK.
    Biochem Biophys Res Commun; 2003 Aug 22; 308(2):320-4. PubMed ID: 12901871
    [Abstract] [Full Text] [Related]

  • 2. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
    Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, Väänänen HK.
    Clin Lab; 2006 Aug 22; 52(9-10):499-509. PubMed ID: 17078477
    [Abstract] [Full Text] [Related]

  • 3. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model.
    Rissanen JP, Suominen MI, Peng Z, Halleen JM.
    Calcif Tissue Int; 2008 Feb 22; 82(2):108-15. PubMed ID: 18084692
    [Abstract] [Full Text] [Related]

  • 4. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
    Halleen JM.
    Anticancer Res; 2003 Feb 22; 23(2A):1027-9. PubMed ID: 12820342
    [Abstract] [Full Text] [Related]

  • 5. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
    Halleen JM, Ylipahkala H, Alatalo SL, Janckila AJ, Heikkinen JE, Suominen H, Cheng S, Väänänen HK.
    Calcif Tissue Int; 2002 Jul 22; 71(1):20-5. PubMed ID: 12073156
    [Abstract] [Full Text] [Related]

  • 6. Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis).
    Alatalo SL, Ivaska KK, Waguespack SG, Econs MJ, Väänänen HK, Halleen JM.
    Clin Chem; 2004 May 22; 50(5):883-90. PubMed ID: 15016726
    [Abstract] [Full Text] [Related]

  • 7. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
    Hannon RA, Clowes JA, Eagleton AC, Al Hadari A, Eastell R, Blumsohn A.
    Bone; 2004 Jan 22; 34(1):187-94. PubMed ID: 14751577
    [Abstract] [Full Text] [Related]

  • 8. Development of a kinetic assay for band 5b tartrate-resistant acid phosphatase activity in serum.
    Nakanishi M, Yoh K, Miura T, Ohasi T, Rai SK, Uchida K.
    Clin Chem; 2000 Apr 22; 46(4):469-73. PubMed ID: 10759470
    [Abstract] [Full Text] [Related]

  • 9. [Development for the determination of band 5b tartrate-resistant acid phosphatase activity in serum].
    Uchida K, Nakanishi M, Yoh K.
    Rinsho Byori; 2001 Jan 22; 49(1):51-5. PubMed ID: 11215484
    [Abstract] [Full Text] [Related]

  • 10. Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells.
    Janckila AJ, Parthasarathy RN, Parthasarathy LK, Seelan RS, Hsueh YC, Rissanen J, Alatalo SL, Halleen JM, Yam LT.
    J Leukoc Biol; 2005 Feb 22; 77(2):209-18. PubMed ID: 15542543
    [Abstract] [Full Text] [Related]

  • 11. Tartrate-resistant acid phosphatase forms complexes with alpha2-macroglobulin in serum.
    Brehme CS, Roman S, Shaffer J, Wolfert R.
    J Bone Miner Res; 1999 Feb 22; 14(2):311-8. PubMed ID: 9933487
    [Abstract] [Full Text] [Related]

  • 12. A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum.
    Alatalo SL, Peng Z, Janckila AJ, Kaija H, Vihko P, Vaananen HK, Halleen JM.
    J Bone Miner Res; 2003 Jan 22; 18(1):134-9. PubMed ID: 12510815
    [Abstract] [Full Text] [Related]

  • 13. [Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker].
    Nowak Z, Konieczna M, Saracyn M, Wańkowicz Z.
    Pol Merkur Lekarski; 2008 Apr 22; 24(142):351-4. PubMed ID: 18634372
    [Abstract] [Full Text] [Related]

  • 14. Specificity and clinical performance of two commercial TRACP 5b immunoassays.
    Ylipahkala H, Fagerlund KM, Janckila AJ, Houston B, Laurie D, Halleen JM.
    Clin Lab; 2009 Apr 22; 55(5-6):223-8. PubMed ID: 19728556
    [Abstract] [Full Text] [Related]

  • 15. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
    Terpos E, de la Fuente J, Szydlo R, Hatjiharissi E, Viniou N, Meletis J, Yataganas X, Goldman JM, Rahemtulla A.
    Int J Cancer; 2003 Sep 01; 106(3):455-7. PubMed ID: 12845688
    [Abstract] [Full Text] [Related]

  • 16. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
    Janckila AJ, Takahashi K, Sun SZ, Yam LT.
    Clin Chem; 2001 Jan 01; 47(1):74-80. PubMed ID: 11148180
    [Abstract] [Full Text] [Related]

  • 17. High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
    Wu ZQ, Zhang Y, Xie E, Song WJ, Yang RX, Yan CJ, Zhang BF, Xu HG.
    PLoS One; 2016 Jan 01; 11(1):e0147554. PubMed ID: 26800211
    [Abstract] [Full Text] [Related]

  • 18. Altered serum levels of the osteoclast-specific TRACP 5b isoform in Chinese children undergoing orthodontic treatment.
    Tang SJ, Meikle MC, MacLaine JK, Wong RW, Rabie BM.
    Eur J Orthod; 2013 Apr 01; 35(2):169-74. PubMed ID: 22467569
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth.
    Chen CJ, Chao TY, Janckila AJ, Cheng SN, Ku CH, Chu DM.
    J Pediatr Endocrinol Metab; 2005 Jan 01; 18(1):55-62. PubMed ID: 15679069
    [Abstract] [Full Text] [Related]

  • 20. Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis.
    Janckila AJ, Neustadt DH, Nakasato YR, Halleen JM, Hentunen T, Yam LT.
    Clin Chim Acta; 2002 Jun 01; 320(1-2):49-58. PubMed ID: 11983200
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.